ASP Isotopes Hosts Inaugural Capital Markets Day and Provides Operational Update

At its inaugural Capital Markets Day, ASP Isotopes outlined a strategy targeting $300 million EBITDA by 2031 through nuclear medicine, helium, and LNG production, with commercial shipments commencing soon.